Stock AMED AMEDISYS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Amedisys, Inc.

Equities

AMED

US0234361089

Real-time Estimate Cboe BZX
Other stock markets
 03:56:40 2024-04-23 pm EDT 		5-day change 1st Jan Change
91.25 USD +0.01% Intraday chart for Amedisys, Inc. +0.14% -3.88%
Mar. 25 UnitedHealth's Takeover of Amedisys Expected to Close Despite Potential Regulatory Hurdles, RBC Says MT
Mar. 25 Amedisys Acquisition by UnitedHealth Unit Seen to Close Despite Potential DOJ Probe, RBC Says MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
UnitedHealth's Takeover of Amedisys Expected to Close Despite Potential Regulatory Hurdles, RBC Says
MT
Amedisys Acquisition by UnitedHealth Unit Seen to Close Despite Potential DOJ Probe, RBC Says
MT
RBC Raises Price Target on Amedisys to $100 From $97 to Reflect UnitedHealth Deal Terms, Keeps Outperform Rating
MT
Oregon's health authority reviewing UnitedHealth's acquisition of Amedisys
RE
UnitedHealth Faces Antitrust Probe in US
MT
Amedisys: Q4 Earnings Snapshot
AQ
Earnings Flash (AMED) AMEDISYS Reports Q4 EPS $0.94
MT
Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results
AQ
Amedisys, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis
AQ
Amedisys, Inc. Offers Advanced Molecular Testing to its Care Centers in Collaboration with Patient Choice Laboratories
CI
Amedisys Finds Answer Key in Medalogix Pulse
AQ
Tranche Update on Amedisys, Inc.'s Equity Buyback Plan announced on February 9, 2023.
CI
Amedisys Q3 Adjusted Earnings, Net Service Revenue Decline
MT
Amedisys: Q3 Earnings Snapshot
AQ
Earnings Flash (AMED) AMEDISYS Posts Q3 EPS $0.98
MT
Amedisys, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Amedisys Reports Third Quarter 2023 Financial Results
AQ
Amedisys Celebrates National Quality Week
AQ
Cantor Fitzgerald Adjusts Price Target on Amedisys to $101 From $100, Maintains Neutral Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AMED Stock
  4. News Amedisys, Inc.